// App-Quantinova.ai

T4050 2015 AHA : Efficacy and Safety of Dabigatran Compared with Warfarin in Patients with Atrial Fibrillation and Normal Renal Function Over Time: Insights From the RE-LY Trial

Researchers

Presenter

  • Stefan H Hohnloser

Principal Investigators

  • Jonas Oldgren

  • Ulrika Andersson

  • Stuart J Connolly

  • John W Eikelboom

  • Michael D Ezekowitz

  • Paul A Reilly

  • Salim Yusuf

  • Lars Wallentin

Medical Centers

  • Population Health Res Inst, Hamilton, ON, Canada

  • Uppsala Clinical Research Center, Uppsala, Sweden

  • Thomas Jefferson Medical Coll and the Heart Ctr, Wynnewood, PA

  • Goethe University, Frankfurt, Germany

Locations

  • United States

  • Canada

  • Germany

  • Sweden

Companies

  • Boehringer Ingelheim

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Arrhythmia

  • Stroke

Biomarkers

  • Creatinine

Drug/Treatment

  • Pradax

  • Warfarin

Outcome

  • N/A

Study Design

  • non inferiority

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved